News Focus
News Focus
Followers 210
Posts 32738
Boards Moderated 1
Alias Born 06/30/2009

Re: scottsmith post# 238017

Tuesday, 08/21/2018 4:16:27 PM

Tuesday, August 21, 2018 4:16:27 PM

Post# of 405181
Please pardon the interruption. I'm going to be as selective in my response as I was when I picked up the thread, which was here:
"BTW we have heard talk of other diseases affected by P. Can’t tell you when but it was mentioned."

A response to that statement included the Dr B bio (absent RVNC) and I thought that that absence was worth mentioning even though I caught a lot of crap in the past for mentioning it. (https://investorshub.advfn.com/boards/read_msg.aspx?message_id=141928563&txt2find=revance

The old Cellceutix Our Team page bio included this:
"Dr. Bertolino also held the position of Executive Vice President and Chief Medical Officer at Revance Therapeutics, where he, among other responsibilities, supervised all aspects of clinical staff and programs and regulatory affairs. -
See more at: https://web.archive.org/web/20160718014204/http://cellceutix.com:80/team#sthash.s5HNCJVU.dpuf

That reference has been removed:
http://www.ipharminc.com/senior-management/


I don't know what they call it nowadays but that used to be called revisionist history. Maybe it's "editing for space".
Dr. B's background right up until his appearance at CTIX from Innovation Dermatologics, Inc. (also absent from the bio) was focused on dermatology. Didn't mean to detract from your otc product discussion but I was distracted by that shiny object...Dr. B's bio.


https://gust.com/companies/innovation_dermatologics_inc

But can it core A apple?
Yes Ralph, of course it can core A apple.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y